µ¼Ê¦ÐÕÃû£ºÍô²½º£
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º38
ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£º
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º ¶ñÐÔÖ×ÁöµÄ×ÛºÏÕïÖÎ
Ñо¿ÁìÓò£º ¶ñÐÔÖ×ÁöµÄ×ÛºÏÕïÖÎ [ÊÕÆð]
ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºwbhself@sina.com
¸öÈ˼òÊö :
Íô²½º££¬²©Ê¿£¬¸±½ÌÊÚ£¬½ËÕÊ¡ËÕ±±ÈËÃñÒ½ÔºÖ×Áö¿Æ¸±Ö÷ÈΣ¬Ë¶Ê¿Éúµ¼Ê¦£¬ÈÎËÕ±±ÈËÃñÒ½ÔºÖ×ÁöÑо¿ËùËù³¤¡£2006Äê6Ô±ÏÒµÓÚ»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ»ñҽѧ²©Ê¿Ñ§Î»¡£2010Äê11ÔÂ-2011Äê1Ô£¬ÓɽËÕÊ¡ÎÀÉúÌü¹«Åɸ°µÂ¹úÀ³±ÈÎý´óѧҽԺÖ×ÁöÄÚ¿Æ£¬·ÅÁÆ¿ÆÑ§Ï°¡£2013Äê3ÔÂ-2013Äê4Ô£¬ÓɽËÕÊ¡Íâר¾Ö¹«Åɸ°µÂ¹ú¸¥À³±¤´óѧÖ×ÁöÕïÖÎÖÐÐÄѧϰ¡£2012ÄêÈëÑ¡ÑïÖÝÊÐÒ½Ñ§ÖØµãÈ˲ţ¬2013ÄêÈëÑ¡½ËÕÊ¡µÚËÄÆÚ¡°333¸ß²ã´ÎÈ˲ÅÅàÑø¹¤³Ì¡±µÚÈý²ã´ÎÅàÑø¶ÔÏó¡£2014¡¢2016Äê¶È»ñÊ¡¡°333¹¤³Ì¡±ÅàÑø×ʽð×ÊÖúÖ÷³ÖÈ«ÄÔ·ÅÁÆÊ±Í¨¹ýº£Âí±£»¤¼¼ÊõÔ¤·ÀÈÏÖª¹¦ÄÜÕϰµÄÍÆ¹ãÓ¦ÓÃÑо¿¡£2017Äê»ñ½ËÕÔ¤·Àҽѧ¿Æ¼¼½±¡£Í¬Ê±£¬¼æÈλªÈËÖ×Áö·ÅÉäÖÎÁÆÐ×÷×éµÚÒ»½ì·Î°©¹¤×÷ίԱ»á³£ÎñίԱ£»Öйú¿¹°©Ð»áÖ×Áö·ÅÁÆöλÔÓéÀֵǼÈë¿ÚÏÂÔØÎ¯Ô±»áÈ«¹úίԱ£»Öйú¿¹°©Ð»á±ÇÑʰ©öλÔÓéÀֵǼÈë¿ÚÏÂÔØÎ¯Ô±»áµÚÒ»½ìÈ«¹úÇàÄêίԱ£»½ËÕÊ¡ÉúÎïҽѧ¹¤³Ìѧ»áҽѧÎïÀíöλÔÓéÀֵǼÈë¿ÚÏÂÔØÎ¯Ô±»á³£ÎñίԱ£»½ËÕÊ¡¿¹°©Ð»áÖ×Áö·ÅÁÆöλÔÓéÀֵǼÈë¿ÚÏÂÔØÎ¯Ô±»áίԱ£»½ËÕʡҽѧ»á¡¢Ò½Ê¦Ð»á»¯ÁÆÓëÉúÎïÖÎÁÆöλÔÓéÀֵǼÈë¿ÚÏÂÔØÎ¯Ô±»áίԱ£»½ËÕÊ¡ºËѧ»áÖ×Áö·ÅÉäÖÎÁÆÎ¯Ô±»á¸±Ö÷ÈÎίԱ£»ÑïÖÝÊзÅÉäÖ×ÁöÖÎÁÆÑ§öλÔÓéÀֵǼÈë¿ÚÏÂÔØÎ¯Ô±»á¸±Ö÷ÈÎίԱ£»ÑïÖÝÊл¯ÁÆÓëÉúÎïÖÎÁÆöλÔÓéÀֵǼÈë¿ÚÏÂÔØÎ¯Ô±»á¸±Ö÷ÈÎίԱ£»ÑïÖÝÊÐÂé×íÒ©Æ·ºÍµÚÒ»ÀྫÉñÒ©Æ·¹ÜÀíÅàѵ¹¤×÷Êм¶×¨¼Ò
¿ÆÑй¤×÷ :
ÔÚÑÐÏîÄ¿
1. ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÇàÄê¿ÆÑ§»ù½ðÏîÄ¿£¬¡°·ÇÕû±¶Ìå¶ÔDNAËðÉ˵ÄÄÍÊÜÐÔ¼°Æä²úÉú»úÖÆ¡±£¬ÏîÄ¿²ÎÓëÕß¡£2. Ê¡¡°333¹¤³Ì¡±ÅàÑøÏîÄ¿£¬¡°È«ÄÔ·ÅÁÆÊ±Í¨¹ýº£Âí±£»¤¼¼ÊõÔ¤·ÀÈÏÖª¹¦ÄÜÕϰµÄÍÆ¹ãÓ¦ÓÃÑо¿¡±£¬ÏîÄ¿Ö÷³ÖÈË¡£
´ú±íÐÔÎÄÕÂ
1.Yan Shen, Buhai Wang, Yang Lu, Ammar Ouahab, Qian Li, Jiasheng Tu.A novel tumor-targeted delivery system with hydrophobized hyaluronic acid¨Cspermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery. International Journal of Pharmaceutics. 414(2011): 233-243
2. Bu-Hai Wang*, Wen-Miao Cao, Jie Yu, Xiao-Lei Wang. A Clinical Study of Gemcitabine-based Concurrent Chemoradiotherapy Versus Chemotherapy Alone in Patients with Locally Advanced Pancreatic Cancer. Asian Pacific Journal of Cancer Prevention, Vol 13, 2129-2132
3. *Bu-Hai Wang, Xiao-Lei Wang,Jian-Qi Yang, Wei Hua. Analysis of V5 Predicting Radiation Pneumonitis in Patients Received Thoracic Irradiation Treatment. World Journal of Surgical, Medical and Radiation Oncology, 20143:17-23
4. Shen Y, Wang J, Li Y, Tian Y, Sun H, Ammar O, et al. Co-delivery of siRNA and paclitaxel into cancer cells by hyaluronic acid modified redox-sensitive disulfide-crosslinked PLGA¨CPEI nanoparticles. RSC Adv. 20155(58):46464-79.
5. Buhai Wang,Yizhi Ge, and Xiang Gu. Analysis of esophageal cancer cell lines exposed to X-ray based on radiosensitivity influence by tumor necrosis factor-¦Á. Journal of X-Ray Science and Technology 24 (2016) 761¨C769.
´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Íô²½º£
±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2019-05-27
Ïà¹Ø»°Ìâ/Ö×Áö ÉúÎï ¹¤³Ì ҽѧ ÅàÑø
ºÓ±±½¨Öþ¹¤³ÌѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ʦӿ½\n
µ¼Ê¦ÐÕÃû£ºÊ¦Ó¿½ÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£ººÓ±±½¨Öþ¹¤³ÌѧԺËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÈÈÄÜÀûÓÃϵͳ¹¤³ÌÑо¿ÁìÓò£ºÈÈÄÜÀûÓÃϵͳ¹¤³Ì[ÊÕÆð]ͨѶ·½Ê½:°ì¹«µç»°£º**µç×ÓÓʼþ£ºSyj815@163.com¸öÈ˼òÊö:1985ÄêÖÁ1991ÄêºÓ±±½¨Öþ¹¤³ÌѧԺ³Ç½¨Ïµ¹¤×÷1991ÄêÖÁ199 ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27Î人¹¤³Ì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-¸¶Ðã¾ê
µ¼Ê¦ÐÕÃû£º¸¶Ðã¾êÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º38ËùÊôԺУ£ºÎ人¹¤³Ì´óѧËùÊôԺϵ£º²ÄÁÏ¿ÆÑ§Ó빤³ÌѧԺְ³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º²ÄÁÏѧÑо¿ÁìÓò£º²ÄÁϼӹ¤¹¤³ÌÑо¿ÁìÓò£º²ÄÁϼӹ¤¹¤³Ì[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºfuxiujuan2008@163.comͨѶµØÖ·£ººþ±±Î人¹â¹Èһ·Î人¹¤³Ì´óѧ²ÄÁÏѧԺ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27Î人¹¤³Ì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-»ÆÔª·å
µ¼Ê¦ÐÕÃû£º»ÆÔª·åÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º39ËùÊôԺУ£ºÎ人¹¤³Ì´óѧËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖÇÄÜ¿ØÖÆ¡¢»úµçÒ»Ì廯װÖÃÑо¿ÁìÓò£ºÖÇÄÜ¿ØÖÆ¡¢»úµçÒ»Ì廯װÖÃ[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£º**@qq.comͨѶµØÖ·£ºÎ人¶«ºþм¼Êõ¿ª·¢Çø¸ßдóµÀ999ºÅ¸öÈ˼òÊö:³¤ÆÚÓëÆóÒµºÏ×÷£¬Ö÷³ÖºÍ²ÎÓë ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ºÓ±±½¨Öþ¹¤³ÌѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÍõάÓñ\n
µ¼Ê¦ÐÕÃû£ºÍõάÓñÐÔ±ð£ºÈËÆøÖ¸Êý£º37ËùÊôԺУ£ººÓ±±½¨Öþ¹¤³ÌѧԺËùÊôԺϵ£ºÖ°³Æ£ºÕý¸ß¼¶¹¤³Ìʦµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º½á¹¹¹¤³ÌÑо¿ÁìÓò£º½¨Öþ½á¹¹£»µØ»ù»ù´¡£»½¨Öþ½ÚÄÜ£»½¨ÖþвÄÁÏÑо¿ÁìÓò£º½¨Öþ½á¹¹£»µØ»ù»ù´¡£»½¨Öþ½ÚÄÜ£»½¨ÖþвÄÁÏ[ÊÕÆð]ͨѶ·½Ê½:°ì¹«µç»°£º**µç×ÓÓʼþ£ºWeiyu_wang@163.com¸öÈË ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27Î人¹¤³Ì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÀîºéÇ¿
µ¼Ê¦ÐÕÃû£ºÀîºéÇ¿ÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º37ËùÊôԺУ£ºÎ人¹¤³Ì´óѧËùÊôԺϵ£ºÖ°³Æ£º¼æÖ°¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º¸´ÔÓÄÑ´¦Àí×ÊÔ´ÀûÓᢿóÎï²ÄÁÏÑо¿ÁìÓò£º¸´ÔÓÄÑ´¦Àí×ÊÔ´ÀûÓᢿóÎï²ÄÁÏ[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºlhq18@163.comͨѶµØÖ·£ºÎ人ÊкéÉ½ÇøÐÛ³þ´ó½Ö693ºÅÎ人¹¤³Ì´óѧ¸öÈ˼òÊö: ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27Î人¹¤³Ì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Áú±üÎÄ
µ¼Ê¦ÐÕÃû£ºÁú±üÎÄÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º37ËùÊôԺУ£ºÎ人¹¤³Ì´óѧËùÊôԺϵ£ºÖ°³Æ£ºÌØÆ¸½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º¹¤Òµ½á¾§¡¢»¯¹¤ÈÈÁ¦Ñ§Ñо¿ÁìÓò£º¹¤Òµ½á¾§¡¢»¯¹¤ÈÈÁ¦Ñ§[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºBingwen_long@163.comͨѶµØÖ·£ºÎ人¹¤³Ì´óѧ»¯¹¤ÓëÖÆÒ©Ñ§Ôº ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27Î人¹¤³Ì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÁõìãÇç
µ¼Ê¦ÐÕÃû£ºÁõìãÇçÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º36ËùÊôԺУ£ºÎ人¹¤³Ì´óѧËùÊôԺϵ£ºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºË®ÎÛȾ¿ØÖÆ¡¢»·¾³¹æ»®¡¢Çå½àÉú²úÉóºËÓë»·¾³ÆÀ¼Û¡¢¿óɽ»·¾³±£»¤Ñо¿ÁìÓò£ºË®ÎÛȾ¿ØÖÆ¡¢»·¾³¹æ»®¡¢Çå½àÉú²úÉóºËÓë»·¾³ÆÀ¼Û¡¢¿óɽ»·¾³±£»¤[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£º**@qq.comͨѶµØÖ·£ºÎä ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27Î人¹¤³Ì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ºéººÓñ
µ¼Ê¦ÐÕÃû£ººéººÓñÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º36ËùÊôԺУ£ºÎ人¹¤³Ì´óѧËùÊôԺϵ£ºÖ°³Æ£ºÈý¼¶½ÌÊÚ¼°ÒÔÉϵ¼Ê¦ÀàÐÍ£º²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÄ¿±ê¼ì²â£¬Í¼Ïñ´¦Àí£¬Ä£Ê½Ê¶±ð£¬µ¼º½Óë¾«È·ÖÆµ¼£¬ÖÇÄÜ¿ØÖÆÏµÍ³£¬»úÆ÷ÊÓ¾õ¡£Ñо¿ÁìÓò£ºÄ¿±ê¼ì²â£¬Í¼Ïñ´¦Àí£¬Ä£Ê½Ê¶±ð£¬µ¼º½Óë¾«È·ÖÆµ¼£¬ÖÇÄÜ¿ØÖÆÏµÍ³£¬»úÆ÷ÊÓ¾õ¡£[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27Î人¹¤³Ì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-×ÞÁ¬Ó¢
µ¼Ê¦ÐÕÃû£º×ÞÁ¬Ó¢ÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º36ËùÊôԺУ£ºÎ人¹¤³Ì´óѧËùÊôԺϵ£ºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÇ¶ÈëʽϵͳÉè¼Æ¡¢VLSI¼¯³Éµç·Éè¼ÆÑо¿ÁìÓò£ºÇ¶ÈëʽϵͳÉè¼Æ¡¢VLSI¼¯³Éµç·Éè¼Æ[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºzou_ly@126.comͨѶµØÖ·£ººþ±±Ê¡Î人ÊнÏÄÇøÁ÷·¼Î人¹¤³Ì´óѧµç ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27Î人¹¤³Ì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Àî×Ô³É
µ¼Ê¦ÐÕÃû£ºÀî×Ô³ÉÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º36ËùÊôԺУ£ºÎ人¹¤³Ì´óѧËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºµçÁ¦µç×ÓÓëµç»úÇý¶¯¡¢¼ÆËã»ú¼¯³É¿ØÖÆÏµÍ³Ñо¿ÁìÓò£ºµçÁ¦µç×ÓÓëµç»úÇý¶¯¡¢¼ÆËã»ú¼¯³É¿ØÖÆÏµÍ³[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºzcli@wit.edu.cnͨѶµØÖ·£ººþ±±Ê¡Î人Êж«ºþ¸ßÐÂÇø¹â¹Èһ·2 ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27Î人¹¤³Ì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ºÎ¼Òʤ
µ¼Ê¦ÐÕÃû£ººÎ¼ÒʤÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º36ËùÊôԺУ£ºÎ人¹¤³Ì´óѧËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º½á¹¹Ç¿¶È¼°Ê§Ð§·ÖÎöÑо¿ÁìÓò£º½á¹¹Ç¿¶È¼°Ê§Ð§·ÖÎö[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºhhjjss88@163.comͨѶµØÖ·£ºÎ人Êйâ¹Èһ·206ºÅ¸öÈ˼òÊö:ºÎ¼Òʤ£¬½ÌÊÚ£¬ÏÖΪÖйú¸¯Ê´Óë·À»¤Ñ§»á»· ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27Î人¹¤³Ì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Íõ´«ÐÂ
µ¼Ê¦ÐÕÃû£ºÍõ´«ÐÂÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º36ËùÊôԺУ£ºÎ人¹¤³Ì´óѧËùÊôԺϵ£º²ÄÁÏ¿ÆÑ§Ó빤³ÌѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º²ÄÁÏѧÑо¿ÁìÓò£º±¡Ä¤²ÄÁÏÑо¿ÁìÓò£º±¡Ä¤²ÄÁÏ[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£º**@qq.comͨѶµØÖ·£º²ÄÁÏÎïÀí½ÌÑÐÊÒ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27Î人¹¤³Ì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÎâÇï·ï
µ¼Ê¦ÐÕÃû£ºÎâÇï·ïÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º35ËùÊôԺУ£ºÎ人¹¤³Ì´óѧËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÂí¿Ë˼Ö÷ÒåÂ×Àí˼Ïë¡¢Éú̬ÎÄÃ÷½¨É衢˼ÏëÕþÖνÌÓýÑо¿ÁìÓò£ºÂí¿Ë˼Ö÷ÒåÂ×Àí˼Ïë¡¢Éú̬ÎÄÃ÷½¨É衢˼ÏëÕþÖνÌÓý[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£º**@qq.comͨѶµØÖ·£ºÎ人¹¤³Ì´óѧÂí¿Ë˼Ö÷ÒåѧԺ¸ö ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27Î人¹¤³Ì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-¹Å˫ϲ
µ¼Ê¦ÐÕÃû£º¹Å˫ϲÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º35ËùÊôԺУ£ºÎ人¹¤³Ì´óѧËùÊôԺϵ£ºÖ°³Æ£ºÌØÆ¸½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÒ©ÎïºÏ³É»¯Ñ§£»ÖÆÒ©¹¤³Ì£»ÊÖÐԺϳÉÓëÊÖÐÔ·Ö×Óʶ±ðÑо¿ÁìÓò£ºÒ©ÎïºÏ³É»¯Ñ§£»ÖÆÒ©¹¤³Ì£»ÊÖÐԺϳÉÓëÊÖÐÔ·Ö×Óʶ±ð[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºshuangxigu@163.comͨѶµØÖ·£ºÎ人ÊÐ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27Î人¹¤³Ì´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-µËȪÈÙ
µ¼Ê¦ÐÕÃû£ºµËȪÈÙÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º35ËùÊôԺУ£ºÎ人¹¤³Ì´óѧËùÊôԺϵ£ºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º°ëµ¼Ìå¹âµç²ÄÁÏ£¬ÄÉÃײÄÁÏÑо¿ÁìÓò£º°ëµ¼Ìå¹âµç²ÄÁÏ£¬ÄÉÃײÄÁÏ[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºquanrongdeng@wit.edu.cnͨѶµØÖ·£ººþ±±Ê¡Î人Êж«ºþм¼Êõ¿ª·¢Çø¹â¹Èһ·206 ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
